ASND Ascendis Pharma-ADR
Performance
-1.47% Past Week
Market Cap
5.91B
Day’s Range
52W Range
Volume (3M)
263.13K
Price-Earnings Ratio
-9.72
Revenue
52.96M
About Ascendis Pharma-ADR
Ascendis Pharma A/S is a biotechnology company that is dedicated to developing prodrug therapies for unmet medical needs. Founded in 2007, the company is based in Copenhagen, Denmark, and operates internationally. The company is listed on NASDAQ GS using the ticker ASND. Add this instrument to your watchlist to stay up to date on ASND share price news.
Show More-
Employees
Hellerup, Capital Region, US
HQ
2006
Founded
Jan Møller Mikkelsen
CEO
Upcoming Earnings
10
MAY
REPORTS
Ascendis Pharma-ADR Q1 2023 earnings report is expected to be released after market open
Consensus
Moderate Buy
Price Target
129.33
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
47
Low
Industry
Avg. 47
44
Environment
48
Social
48
Governance
People Also Bought
- MTZ MasTec Inc 0.78%
- MLM Martin Marietta Materials Inc 1.55%
- ALNY Alnylam Pharmaceuticals Inc 0.40%
JAMF Jamf Holding Corp. 2.91%
ARGX Argenx SE-ADR 0.82%
104.90